Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Nov;46(6):1007-1016.
doi: 10.1002/jimd.12678. Epub 2023 Oct 10.

The challenge of understanding and predicting phenotypic diversity in urea cycle disorders

Affiliations
Review

The challenge of understanding and predicting phenotypic diversity in urea cycle disorders

Roland Posset et al. J Inherit Metab Dis. 2023 Nov.

Abstract

The Urea Cycle Disorders Consortium (UCDC) and the European registry and network for Intoxication type Metabolic Diseases (E-IMD) are the worldwide largest databases for individuals with urea cycle disorders (UCDs) comprising longitudinal data from more than 1100 individuals with an overall long-term follow-up of approximately 25 years. However, heterogeneity of the clinical phenotype as well as different diagnostic and therapeutic strategies hamper our understanding on the predictors of phenotypic diversity and the impact of disease-immanent and interventional variables (e.g., diagnostic and therapeutic interventions) on the long-term outcome. A new strategy using combined and comparative data analyses helped overcome this challenge. This review presents the mechanisms and relevant principles that are necessary for the identification of meaningful clinical associations by combining data from different data sources, and serves as a blueprint for future analyses of rare disease registries.

Keywords: E-IMD; UCDC; prediction modeling; rare disease registries; urea cycle disorders.

PubMed Disclaimer

References

REFERENCES

    1. Seminara J, Tuchman M, Krivitzky L, et al. Establishing a consortium for the study of rare diseases: the urea cycle disorders consortium. Mol Genet Metab. 2010;100(Suppl 1):S97-S105.
    1. Kolker S, Dobbelaere D, Haberle J, et al. Networking across Borders for individuals with organic acidurias and urea cycle disorders: the E-IMD consortium. JIMD Rep. 2015;22:29-38.
    1. Haberle J, Burlina A, Chakrapani A, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision. J Inherit Metab Dis. 2019;42(6):1192-1230.
    1. Posset R, Garbade SF, Boy N, et al. Transatlantic combined and comparative data analysis of 1095 patients with urea cycle disorders-a successful strategy for clinical research of rare diseases. J Inherit Metab Dis. 2019;42(1):93-106.
    1. Kolker S, Garcia-Cazorla A, Valayannopoulos V, et al. The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation. J Inherit Metab Dis. 2015;38(6):1041-1057.

Publication types